Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sandoparin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Outpatient subcutaneous therapies are becoming more and more common, such as the use of low-molecular-weight heparins (LMWH) for… Expand
  • figure 1
2009
2009
Heparin is an injectable anticoagulant that prevents coagulation. There are presently high and low molecular heparins as well as… Expand
2005
2005
A randomized open trial was undertaken to compare the antithrombotic efficacy of a low molecular weight heparin (LMWH; Sandoparin… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2004
2004
  • A. Encke
  • Langenbecks Archiv für Chirurgie
  • 2004
  • Corpus ID: 28145869
Niedermolekulare Heparine (NMH) werden aus unfraktioniertem Heparin dutch Gelchromatographie, Alkoholf/illung oder enzymatische… Expand
1995
1995
We report a patient who developed infiltrated plaques at the sites of subcutaneous injection of a low‐molecular‐weight heparin… Expand
1995
1995
Recent studies have indicated a beneficial effect of one particular low molecular weight heparin preparation (Fragmin) on lipid… Expand
1993
1993
In a prospective, randomized study in patients with hip fracture we discuss whether a single dose of low-molecular-heparin… Expand
1992
1992
Since the beginning of the clinical use of low molecular weight (LMW) heparins their thrombolytic or profibrinolytic potency has… Expand
1990
1990
In three studies the effect and secondary effect of low molecular weight heparin (LMWH) were examined. Study 1: LMWH (Embolex-LM… Expand
1990
1990
In 3 Studien wurden Wirkung und Nebenwirkung von LMW-Heparin untersucht. Studie 1: LMW-Heparin-DHE (Embolex-LM, n = 464) versus… Expand